TLR ligands differentially modulate T cell responses to acute and chronic antigen presentation

Journal of Immunology

Volumn 179, Issue 12, 2007, Pages 7999-8008

  Singh, Nevil J ^a   Cox, Maureen ^b   Schwartz, Ronald H ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF ALABAMA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANYLASPARAGINYLGLUTAMYLARGINYLALANYLASPARTYLLEUCYLISOLEUCYLALANYL TYROSYLLEUCYLLYSYLGLUTAMINYLALANYLTHREONYLLYSINE; BACTERIUM LIPOPOLYSACCHARIDE; CPG OLIGODEOXYNUCLEOTIDE; ISOLEUCYLPHENYLALANYLALANYLGLYCYLISOLEUCYLLYSYLLYSYLLYSYLALANYL GLUTAMYLARGINYLALANYLASPARTYLLEUCYLISOLEUCYLALANYLTYROSYLLEUCYLLYSYL GLUTAMINYLALANYLTHREONYLALANYLLYSINE; PEPTIDE DERIVATIVE; POLYINOSINIC POLYCYTIDYLIC ACID; T LYMPHOCYTE ANTIGEN; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG; AUTOANTIGEN; LIGAND; LIPOPOLYSACCHARIDE; PEPTIDE;

ADJUVANT THERAPY; ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CELL EXPANSION; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG DOSE TITRATION; EXPERIMENTAL MODEL; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IN VIVO STUDY; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ANIMAL; AUTOIMMUNE DISEASE; DRUG POTENTIATION; IMMUNOLOGY; METABOLISM;

ANIMALS; ANTIGEN PRESENTATION; AUTOANTIGENS; AUTOIMMUNE DISEASES; IMMUNE TOLERANCE; LIGANDS; LIPOPOLYSACCHARIDES; MICE; PEPTIDES; T-LYMPHOCYTES; TOLL-LIKE RECEPTORS;

EID: 40049092527     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.12.7999     Document Type: Article

References (70)

1. Singh, N. J., and R. H. Schwartz. 2006. Primer: mechanisms of immunologic tolerance. Nat. Clin. Pract. Rheum. 2: 44-52.
2. Dresser, D. W. 1962. Specific inhibition of antibody production, II: paralysis induced in adult mice by small quantities of protein antigen. Immunology 5: 378-388.
3. Claman, H. N. 1963. Tolerance to a protein antigen in adult mice and the effect of nonspecific factors. J. Immunol. 91: 833-839.
4. Lafferty, K. J., and A. J. Cunningham. 1975. A new analysis of allogeneic interactions. Aust. J. Exp. Biol. Med. Sci. 53: 27-42.
5. Jenkins, M. K., and R. H. Schwartz. 1987. Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J. Exp. Med. 165: 302-319.
6. Janeway, C. A., Jr. 1992. The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol. Today 13: 11-16.
7. Matzinger, P. 1994. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12: 991-1045.
8. Liu, Y., and C. A. Janeway, Jr. 1991. Microbial induction of costimulatory activity for CD4 T-cell growth. Int. Immunol. 3: 323-332.
9. Gallucci, S., M. Lolkema, and P. Matzinger. 1999. Natural adjuvants: endogenous activators of dendritic cells. Nat. Med. 5: 1249-1255.
10. Medzhitov, R., P. Preston-Hurlburt, and C. A. Janeway, Jr. 1997. A human homologue of the Drosophila toll protein signals activation of adaptive immunity. Nature 388: 394-397.
11. Janeway, C. A., Jr. 1989. Approaching the asymptote: evolution and revolution in immunology. Cold Spring Harbor Symp. Quant. Biol. 54: 1-13.
12. Vella, A. T., J. E. McCormack, P. S. Linsley, J. W. Kappler, and P. Marrack. 1995. Lipopolysaccharide interferes with the induction of peripheral T cell death. Immunity 2: 261-270.
13. Khoruts, A., A. Mondino, K. A. Pape, S. L. Reiner, and M. K. Jenkins. 1998. A natural immunological adjuvant enhances T cell clonal expansion through a CD28-dependent, interleukin (IL)-2-independent mechanism. J. Exp. Med. 187: 225-236.
14. Thornley, T. B., M. A. Brehm, T. G. Markees, L. D. Shultz, J. P. Mordes, R. M. Welsh, A. A. Rossini, and D. L. Greiner. 2006. TLR agonists abrogate costimulation blockade-induced prolongation of skin allografts. J. Immunol. 176: 1561-1570.
15. Leadbetter, E. A., I. R. Rifkin, A. M. Hohlbaum, B. C. Beaudette, M. J. Shlomchik, and A. Marshak-Rothstein. 2002. Chromatin-IgG complexes activate B cells by dual engagement of IgM and toll-like receptors. Nature 416: 603-607.
16. + T cell-mediated suppression by dendritic cells. Science 299:1033-1036.
17. Garza, K. M., S. M. Chan, R. Suri, L. T. Nguyen, B. Odermatt, S. P. Schoenberger, and P. S. Ohashi. 2000. Role of antigen-presenting cells in mediating tolerance and autoimmunity. J. Exp. Med. 191: 2021-2027.
18. Singh, N. J., C. Chen, and R. H. Schwartz. 2006. The impact of T cell intrinsic antigen adaptation on peripheral immune tolerance. PLoS Biol. 4: e430.
19. + T cells in vivo: multiple thresholds in response to a constant level of antigen presentation. J. Immunol. 167: 2030-2039.
20. + T cells. J. Exp. Med. 198: 1107-1117.
21. Schwartz, R. H. 2003. T cell anergy. Annu. Rev. Immunol. 21: 305-334.
22. Chiodetti, L., S. Choi, D. L. Barber, and R. H. Schwartz. 2006. Adaptive tolerance and clonal anergy are distinct biochemical States. J. Immunol. 176: 2279-2291.
23. Schwartz, R. H. 1996. Models of T cell anergy: is there a common molecular mechanism? J. Exp. Med. 184: 1-8.
24. Iezzi, G., K. Karjalainen, and A. Lanzavecchia. 1998. The duration of antigenic stimulation determines the fate of naive and effector T cells. Immunity 8: 89-95.
25. Lohr, J., B. Knoechel, V. Nagabhushanam, and A. K. Abbas. 2005. T-cell tolerance and autoimmunity to systemic and tissue-restricted self-antigens. Immunol. Rev. 204: 116-127.
26. Blander, J. M., and R. Medzhitov. 2006. Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 440: 808-812.
27. Grossman, Z., and W. E. Paul. 2000. Self-tolerance: context dependent tuning of T cell antigen recognition. Semin. Immunol. 12: 197-203.
28. Ashwell, J. D., A. L. DeFranco, W. E. Paul, and R. H. Schwartz. 1984. Antigen presentation by resting B cells: radiosensitivity of the antigen-presentation function and two distinct pathways of T cell activation. J. Exp. Med. 159: 881-905.
29. Bendelac, A., and R. Medzhitov. 2002. Adjuvants of immunity: harnessing innate immunity to promote adaptive immunity. J. Exp. Med. 195: F19-F23.
30. Chamaillard, M., S. E. Girardin, J. Viala, and D. J. Philpott. 2003. Nods, nalps and naip: intracellular regulators of bacterial-induced inflammation. Cell. Microbiol. 5: 581-592.
31. Shi, Y., J. E. Evans, and K. L. Rock. 2003. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425: 516-521.
32. Messmer, D., H. Yang, G. Telusma, F. Knoll, J. Li, B. Messmer, K. J. Tracey, and N. Chiorazzi. 2004. High mobility group box protein 1: an endogenous signal for dendritic cell maturation and Th1 polarization. J. Immunol. 173: 307-313.
33. Seong, S. Y., and P. Matzinger. 2004. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat. Rev. Immunol. 4: 469-478.
34. Redmond, W. L., J. Hernandez, and L. A. Sherman. 2003. Deletion of naive CD8 T cells requires persistent antigen and is not programmed by an initial signal from the tolerogenic APC. J. Immunol. 171: 6349-6354.
35. Hamilton-Williams, E. E., A. Lang, D. Benke, G. M. Davey, K. H. Wiesmuller, and C. Kurts. 2005. Cutting edge: TLR ligands are not sufficient to break cross-tolerance to self-antigens. J. Immunol. 174: 1159-1163.
36. Knoechel, B., J. Lohr, E. Kahn, J. A. Bluestone, and A. K. Abbas. 2005. Sequential development of interleukin 2-dependent effector and regulatory T cells in response to endogenous systemic antigen. J. Exp. Med. 202: 1375-1386.
37. Cabbage, S. E., E. S. Huseby, B. D. Sather, T. Brabb, D. Liggitt, and J. Goverman. 2007. Regulatory T cells maintain long-term tolerance to myelin basic protein by inducing a novel, dynamic state of T cell tolerance. J. Immunol. 178: 887-896.
38. + T cell responses to a self peptide. Eur. J. Immunol. 30: 136-144.
39. Munder, M., E. Bettelli, L. Monney, J. M. Slavik, L. B. Nicholson, and V. K. Kuchroo. 2002. Reduced self-reactivity of an autoreactive T cell after activation with cross-reactive non-self-ligand. J. Exp. Med. 196: 1151-1162.
40. Shao, H., S. Lei, S. L. Sun, H. J. Kaplan, and D. Sun. 2003. Conversion of monophasic to recurrent autoimmune disease by autoreactive T cell subsets. J. Immunol. 171: 5624-5630.
41. Katz, J. D., B. Wang, K. Haskins, C. Benoist, and D. Mathis. 1993. Following a diabetogenic T cell from genesis through pathogenesis. Cell 74: 1089-1100.
42. Kuchroo, V. K., R. A. Sobel, T. Yamamura, E. Greenfield, M. E. Dorf, and M. B. Lees. 1991. Induction of experimental allergic encephalomyelitis by myelin proteolipid-protein-specific T cell clones and synthetic peptides. Pathobiology 59: 305-312.
43. Dey, B., Y. G. Yang, F. Preffer, A. Shimizu, K. Swenson, D. Dombkowski, and M. Sykes. 1999. The fate of donor T-cell receptor transgenic T cells with known host antigen specificity in a graft-versus-host disease model. Transplantation 68: 141-149.
44. + T cells pass through an effector phase during the process of in vivo tolerance induction. J. Immunol. 170: 3945-3953.
45. + T cell: receptor-dependent cytolysis in the absence of interleukin-2 production. Science 251: 1228-1231.
46. Seder, R. A., R. N. Germain, P. S. Linsley, and W. E. Paul. 1994. CD28-mediated costimulation of interleukin 2 (IL-2) production plays a critical role in T cell priming for IL-4 and interferon γ production. J. Exp. Med. 179: 299-304.
47. + T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4. J. Immunol. 155: 1032-1036.
48. Kane, L. P., P. G. Andres, K. C. Howland, A. K. Abbas, and A. Weiss. 2001. Akt provides the CD28 costimulatory signal for up-regulation of IL-2 and IFN-γ but not TH2 cytokines. Nat. Immunol. 2: 37-44.
49. Weinberg, A. D., A. T. Vella, and M. Croft. 1998. OX-40: life beyond the effector T cell stage. Semin. Immunol. 10: 471-480.
50. Greenwald, R. J., G. J. Freeman, and A. H. Sharpe. 2005. The B7 family revisited. Annu. Rev. Immunol. 23: 515-548.
51. Marrack, P., J. Kappler, and T. Mitchell. 1999. Type I interferons keep activated T cells alive. J. Exp. Med. 189: 521-530.
52. Mitchell, T. C., D. Hildeman, R. M. Kedl, T. K. Teague, B. C. Schaefer, J. White, Y. Zhu, J. Kappler, and P. Marrack. 2001. Immunological adjuvants promote activated T cell survival via induction of Bcl-3. Nat. Immunol. 2: 397-402.
53. Trinchieri, G., and A. Sher. 2007. Cooperation of toll-like receptor signals in innate immune defense. Nat. Rev. Immunol. 7: 179-190.
54. + T cell proliferation and cytokine production but is not required for tuning T cell reactivity in adaptive tolerance. J. Immunol. 173: 7239-7248.
55. Pulendran, B., P. Kumar, C. W. Cutler, M. Mohamadzadeh, T. Van Dyke, and J. Banchereau. 2001. Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo. J. Immunol. 167: 5067-5076.
56. + T cells acts in an autocrine manner to induce Th2 differentiation. Eur. J. Immunol. 32: 1428-1433.
57. Edwards, A. D., S. P. Manickasingham, R. Sporri, S. S. Diebold, O. Schulz, A. Sher, T. Kaisho, S. Akira, and C. Reis e Sousa. 2002. Microbial recognition via toll-like receptor-dependent and -independent pathways determines the cytokine response of murine dendritic cell subsets to CD40 triggering. J. Immunol. 169: 3652-3660.
58. Abdi, K., N. Singh, and P. Matzinger. 2006. T-cell control of IL-12p75 production. Scand. J. Immunol. 64: 83-92.
59. + T cells. J. Immunol. 168: 1723-1729.
60. Rachmilewitz, J., and A. Lanzavecchia. 2002. A temporal and spatial summation model for T-cell activation: signal integration and antigen decoding. Trends Immunol. 23: 592-595.
61. Manickasingham, S., and C. Reis e Sousa. 2000. Microbial and T cell-derived stimuli regulate antigen presentation by dendritic cells in vivo. J. Immunol. 165: 5027-5034.
62. De Smedt, T., B. Pajak, G. G. Klaus, R. J. Noelle, J. Urbain, O. Leo, and M. Moser. 1998. Antigen-specific T lymphocytes regulate lipopolysaccharide- induced apoptosis of dendritic cells in vivo. J. Immunol. 161: 4476-4479.
63. Kamath, A. T., S. Henri, F. Battye, D. F. Tough, and K. Shortman. 2002. Developmental kinetics and lifespan of dendritic cells in mouse lymphoid organs. Blood 100: 1734-1741.
64. Reis e Sousa, C., and R. N. Germain. 1999. Analysis of adjuvant function by direct visualization of antigen presentation in vivo: endotoxin promotes accumulation of antigen-bearing dendritic cells in the T cell areas of lymphoid tissue. J. Immunol. 162: 6552-6561.
65. Cella, M., A. Engering, V. Pinet, J. Pieters, and A. Lanzavecchia. 1997. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 388: 782-787.
66. Chow, A., D. Toomre, W. Garrett, and I. Mellman. 2002. Dendritic cell maturation triggers retrograde MHC class II transport from lysosomes to the plasma membrane. Nature 418: 988-994.
67. Van-Niel, G., R. Wubbolts, B. T. Ten, S. I. Buschow, F. A. Ossendorp, C. J. Melief, G. Raposo, B. W. van Balkom, and W. Stoorvogel. 2006. Dendritic cells regulate exposure of MHC class II at their plasma membrane by oligoubiquitination. Immunity 25: 885-894.
68. West, M. A., R. P. Wallin, S. P. Matthews, H. G. Svensson, R. Zaru, H. G. Ljunggren, A. R. Prescott, and C. Watts. 2004. Enhanced dendritic cell antigen capture via toll-like receptor-induced actin remodeling. Science 305: 1153-1157.
69. Lanzavecchia, A., and F. Sallusto. 2002. Progressive differentiation and selection of the fittest in the immune response. Nat. Rev. Immunol. 2: 982-987.
70. Reinhardt, R. L., A. Khoruts, R. Merica, T. Zell, and M. K. Jenkins. 2001. Visualizing the generation of memory CD4 T cells in the whole body. Nature 410: 101-105.